Symptomatic Benign Prostatic Hyperplasia

Also known as: Symptomatic benign prostatic hyperplasia (BPH)

DrugDrug NameDrug Description
DB01126DutasterideAn antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) in adult males by inhibiting 5-alpha reductase.
DB01216FinasterideAn antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) and male pattern hair loss in adult males by inhibiting Type II 5-alpha reductase.
DrugDrug NamePhaseStatusCount